DAPHNE GREEN: Open Payments
NPI 1255917746 · BLADENBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 20 payments from 6 companies in 2025. Trend: 2023 $101 · 2024 $118 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $179 |
| Lilly USA, LLC | 6 | $170 |
| Novo Nordisk Inc | 3 | $150 |
| Astellas Pharma US Inc | 3 | $48 |
| Corcept Therapeutics | 2 | $28 |
| Amgen Inc. | 1 | $16 |
Products named: CAPLYTA, Wegovy, ZEPBOUND, MOUNJARO, Veozah, Korlym, OTEZLA.
Industry payments across NC — which companies pay providers there.
